NCCN Patient Webinar: Early Stage Prostate Cancer

Experts provide an overview of early stage prostate cancer and discuss treatment options, side effects, shared decision-making, and more. This webinar is designed for those with prostate cancer, their caregivers, and their families.

Topics Discussed
00:00 - Welcome and introductions
02:06 - Pathology of prostate cancer
03:18 - What do pathologists do?
05:39 - Diagnosing, grading, and staging prostate cancer
09:09 - Prostate needle core biopsies
11:57 - Gleason grading
19:37 - Examining the prostate after surgery
21:01 - Prostate cancer grading after prostatectomy
23:02 - Tumor staging
25:40 - Genetics and genomics in localized prostate cancer
28:17 - Testing continuum
29:26 - Germline versus somatic mutations
30:30 - Genomic testing and risk stratification
34:33 - Do these tests change management decisions?
37:30 - Germline genetics and germline mutations
40:14 - NCCN Guidelines for Genetic/Familial High-Risk Assessment
42:14 - Things to consider for germline genetic testing
43:46 - Decision making for localized prostate cancer
44:50 - Treatment considerations
48:59 - Pros and cons of radiation treatment and surgical treatment
51:39 - Summary and questions to ask your doctors

Question & Answer Session
52:44 - Can cancer be in one nodule or distributed throughout the prostate?
54:20 - Can you provide more information about a transperineal biopsy?
56:17 - If you don't have a multiparametric MRI (mpMRI), is a biparametric MRI acceptable?
57:19 - How long should you wait after a biopsy to be able to get a valid MRI?
59:11 - How long do I have to make a decision for intermediate, moderate and high-risk cancer?
1:00:43 - Is an mpMRI worth it? Does the PI-RAD score help in making a biopsy decision?
1:02:03 - How do you detect that prostate cancer has spread to the lymph nodes and how is this treated?
1:05:18 - What are the pros and cons of proton therapy?
1:07:14 - If the cancer re-occurs after radiation treatment, can the same area be radiated later on?
1:08:54 - What are common questions you hear from patients about biopsy reports?
1:12:16 - Does the presence of the BRCA gene mean you are susceptible to all forms of cancer?
1:13:05 - For somebody who has the mutation of BRCA-2 without prostate cancer, what do they do for early detection?
1:14:42 - Should I send my slides to another cancer center for a second opinion?
1:17:23 - Can you provide more information about hypofractionation and recommendations on how many doses of chemotherapy or radiation is appropriate?
1:19:30 - What does it mean if a PSA score is going up and down?
1:21:25 - If a patient has a pacemaker or for some other reason can't have an MRI, are there other methods of determining the size and risk of cancer?
1:22:20 - Should a patient who visits their primary care doctor yearly insist on having a digital rectal exam?

NCCN Guidelines for Patients DO NOT replace the expertise and clinical judgment of the clinician.

Supporters:
This webinar is supported through the NCCN Foundation and by contributions from our corporate supporters: AstraZeneca and an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.

__________________________________________________________
About NCCN Foundation®:
__________________________________________________________
About NCCN:

Connect with us!